The board of Provident Financial Holdings authorized a stock repurchase plan covering about 305,477 shares. That figure equals 5% of the company's outstanding common stock. The plan will start after the January 2026 repurchase program is completed or expires.

Nursing +63% to HK$56.8 million | Professional more than doubles to HK$36.0 million | Logistics +36% to HK$42.4 million

SAN FRANCISCO — Meta beat investor expectations for third-quarter revenue on Wednesday as it doubles down on a global AI race but the social media giant's profits took a hit due to an $18 billion legal settlement with nearly all US states.

**media[1269247]**MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix') provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026).Q3 2026 Highlights[1]Group revenue of US$245 million increased 19% over the prior corresponding quarter (Q3 2025) driven by continued strong demand for the commercial portfolio, in line with expectations. September sales drov

Third quarter revenue of $1,143 million increased 3% sequentiallyThird quarter operating income of $153 million increased 43% sequentiallyThird quarter net income of $120 million increased 208% sequentially; net income margin of 10.5%Third quarter adjusted EBITDA* of $254 million increased 14% sequentially; adjusted EBITDA margin* of 22.2% increased 204 basis points sequentiallyThird quarter cash provided by operating activities of $192 million and adjusted free cash flow* of $155 millionShareho

Aeroméxico's revenue rose 13.6% year over year. The airline posted an operating margin of 12%. It expects fourth-quarter revenue to grow by approximately 15% year over year.

HOUSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin” or the 'Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on October 20, 2026, and the Company’s common stock will open for trading on The Nasdaq Capital Market

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. ('Alector,” Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced the pricing of an underwritten offering of common stock. Alector is selling 36,600,000 shares of common stock. The shares of common stock are being sold at an offering price of $2.05 per share, which represents a premium of approximately 7.3% over the closing

Fusion Fuel reported its first-half 2026 results and guided to full-year revenue of €16 million to €18 million, an increase of 11%–25% year over year. Its non-IFRS adjusted operating loss narrowed by about 25% to roughly €1.8 million. In July the company completed its acquisition of Royal Uranium, adding interests in uranium and natural gas project areas. Its BrightHy Solutions unit started a 2 MW industrial green hydrogen project in Spain and contributed about €369,000 in engineering revenue during the half.